You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 733 Phase 1 study of ultra-high concentration nitric oxide ablation in relapsed or refractory, unresectable, primary, or metastatic cutaneous and subcutaneous malignancies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
733 Phase 1 study of ultra-high concentration nitric oxide ablation in relapsed or refractory, unresectable, primary, or metastatic cutaneous and subcutaneous malignancies

 

Online download statistics by month:

Online download statistics by month: November 2023 to November 2024

AbstractFullPdf
Nov 2023210010
Dec 20232806
Jan 20241903
Feb 20242204
Mar 20244204
Apr 20245605
May 20244403
Jun 20244402
Jul 20245003
Aug 20244201
Sep 20246403
Oct 20243603
Nov 20247005
Total727052